HealthEquity Historical Financial Ratios

HQY Stock

USD 103.57 0.19 0.18%

HealthEquity is recently reporting on over 110 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as PTB Ratio of 5.64 or Days Sales Outstanding of 30.22 will help investors to properly organize and evaluate HealthEquity financial condition quickly.

Quick Ratio Current Ratio

Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in HealthEquity. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in producer price index.

For more information on how to buy HealthEquity Stock please use our How to Invest in HealthEquity guide.

About HealthEquity Financial Ratios Analysis

HealthEquityFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate HealthEquity investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on HealthEquity financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across HealthEquity history.

HealthEquity Financial Ratios Chart

At this time, HealthEquity's Days Payables Outstanding is fairly stable compared to the past year. Return On Tangible Assets is likely to rise to 0.13 in 2024, whereas Days Sales Outstanding is likely to drop 30.22 in 2024.

Price To Sales Ratio Dividend Yield Ptb Ratio Days Sales Outstanding

Add Fundamental

Price To Sales Ratio

Price to Sales Ratio is figured by comparing HealthEquity stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on HealthEquity sales, a figure that is much harder to manipulate than other HealthEquity multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.

Dividend Yield

Dividend Yield is HealthEquity dividend as a percentage of HealthEquity stock price. HealthEquity dividend yield is a measure of HealthEquity stock productivity, which can be interpreted as interest rate earned on an HealthEquity investment. A financial ratio that shows how much a company pays out in dividends each year relative to its stock price, calculated as annual dividends per share divided by price per share.

Ptb Ratio

Price-to-Book ratio, a financial valuation metric used to compare a company's current market price to its book value. It provides insight into the value that market participants place on the company's equity relative to its net asset value.

Most ratios from HealthEquity's fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into HealthEquity current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in HealthEquity. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in producer price index.

For more information on how to buy HealthEquity Stock please use our How to Invest in HealthEquity guide.At this time, HealthEquity's Days Payables Outstanding is fairly stable compared to the past year. Return On Tangible Assets is likely to rise to 0.13 in 2024, whereas Days Sales Outstanding is likely to drop 30.22 in 2024.

	2023	2024 (projected)
Dividend Yield	0.07	0.0735
Price To Sales Ratio	6.47	6.57

Dividend Yield Price To Sales Ratio

HealthEquity fundamentals Correlations

	Price To Sales Ratio	Dividend Yield	Ptb Ratio	Days Sales Outstanding	Book Value Per Share	Free Cash Flow Yield	Operating Cash Flow Per Share	Capex To Depreciation	Pb Ratio	Ev To Sales	Free Cash Flow Per Share	Roic	Inventory Turnover	Net Income Per Share	Days Of Inventory On Hand	Payables Turnover	Average Inventory	Capex To Revenue	Cash Per Share	Pocfratio	Interest Coverage	Payout Ratio	Capex To Operating Cash Flow	Pfcf Ratio	Days Payables Outstanding	Income Quality
Price To Sales Ratio		0.74	0.88	0.09	-0.11	-0.64	-0.39	0.23	0.88	0.97	-0.27	-0.31	0.36	-0.1	-0.38	0.15	0.09	0.18	0.6	0.84	-0.46	0.74	0.1	-0.06	-0.37	-0.09
Dividend Yield	0.74		0.38	0.47	0.44	-0.88	-0.19	0.17	0.38	0.8	-0.33	-0.78	0.65	-0.58	-0.64	0.25	-0.47	0.33	0.51	0.86	-0.55	1.0	0.35	0.24	-0.31	-0.12
Ptb Ratio	0.88	0.38		-0.29	-0.41	-0.31	-0.38	0.22	1.0	0.78	-0.1	0.04	0.04	0.22	-0.07	0.0	0.43	0.03	0.41	0.6	-0.27	0.38	-0.1	-0.3	-0.28	-0.04
Days Sales Outstanding	0.09	0.47	-0.29		0.3	-0.52	-0.26	0.23	-0.29	0.25	-0.52	-0.54	0.31	-0.52	-0.3	0.04	-0.48	0.43	-0.08	0.44	-0.22	0.47	0.52	0.35	-0.08	-0.22
Book Value Per Share	-0.11	0.44	-0.41	0.3		-0.3	0.59	-0.43	-0.41	0.05	0.27	-0.63	0.76	-0.54	-0.79	0.25	-0.96	-0.12	0.12	0.04	-0.24	0.44	-0.02	0.41	-0.03	0.01
Free Cash Flow Yield	-0.64	-0.88	-0.31	-0.52	-0.3		0.5	-0.36	-0.31	-0.7	0.63	0.5	-0.45	0.44	0.47	-0.2	0.36	-0.52	-0.25	-0.84	0.79	-0.88	-0.56	-0.28	0.36	0.35
Operating Cash Flow Per Share	-0.39	-0.19	-0.38	-0.26	0.59	0.5		-0.52	-0.38	-0.32	0.85	-0.23	0.4	-0.09	-0.42	0.21	-0.49	-0.43	0.14	-0.55	0.47	-0.19	-0.45	-0.02	0.15	0.51
Capex To Depreciation	0.23	0.17	0.22	0.23	-0.43	-0.36	-0.52		0.22	0.16	-0.58	-0.06	-0.31	-0.14	0.32	-0.12	0.38	0.91	-0.12	0.31	-0.01	0.17	0.85	-0.14	0.08	-0.06
Pb Ratio	0.88	0.38	1.0	-0.29	-0.41	-0.31	-0.38	0.22		0.78	-0.1	0.04	0.04	0.22	-0.07	0.0	0.43	0.03	0.41	0.6	-0.27	0.38	-0.1	-0.3	-0.28	-0.04
Ev To Sales	0.97	0.8	0.78	0.25	0.05	-0.7	-0.32	0.16	0.78		-0.28	-0.41	0.5	-0.19	-0.53	0.24	-0.1	0.18	0.56	0.87	-0.5	0.8	0.11	0.02	-0.42	-0.06
Free Cash Flow Per Share	-0.27	-0.33	-0.1	-0.52	0.27	0.63	0.85	-0.58	-0.1	-0.28		0.07	0.16	0.35	-0.19	0.06	-0.16	-0.69	0.21	-0.55	0.4	-0.33	-0.74	-0.36	-0.01	0.44
Roic	-0.31	-0.78	0.04	-0.54	-0.63	0.5	-0.23	-0.06	0.04	-0.41	0.07		-0.57	0.86	0.57	-0.14	0.65	-0.27	-0.29	-0.54	0.01	-0.78	-0.33	-0.33	-0.09	-0.1
Inventory Turnover	0.36	0.65	0.04	0.31	0.76	-0.45	0.4	-0.31	0.04	0.5	0.16	-0.57		-0.38	-0.98	0.35	-0.75	-0.07	0.52	0.27	-0.37	0.65	-0.07	0.33	-0.29	-0.01
Net Income Per Share	-0.1	-0.58	0.22	-0.52	-0.54	0.44	-0.09	-0.14	0.22	-0.19	0.35	0.86	-0.38		0.37	-0.14	0.56	-0.44	-0.01	-0.42	-0.07	-0.58	-0.53	-0.57	-0.31	-0.05
Days Of Inventory On Hand	-0.38	-0.64	-0.07	-0.3	-0.79	0.47	-0.42	0.32	-0.07	-0.53	-0.19	0.57	-0.98	0.37		-0.33	0.78	0.08	-0.5	-0.3	0.4	-0.64	0.07	-0.32	0.27	0.02
Payables Turnover	0.15	0.25	0.0	0.04	0.25	-0.2	0.21	-0.12	0.0	0.24	0.06	-0.14	0.35	-0.14	-0.33		-0.37	0.02	0.16	0.14	-0.18	0.25	-0.03	-0.13	-0.64	0.71
Average Inventory	0.09	-0.47	0.43	-0.48	-0.96	0.36	-0.49	0.38	0.43	-0.1	-0.16	0.65	-0.75	0.56	0.78	-0.37		0.06	-0.04	-0.13	0.28	-0.47	-0.05	-0.39	0.14	-0.07
Capex To Revenue	0.18	0.33	0.03	0.43	-0.12	-0.52	-0.43	0.91	0.03	0.18	-0.69	-0.27	-0.07	-0.44	0.08	0.02	0.06		-0.14	0.36	-0.1	0.33	0.97	0.17	0.14	-0.08
Cash Per Share	0.6	0.51	0.41	-0.08	0.12	-0.25	0.14	-0.12	0.41	0.56	0.21	-0.29	0.52	-0.01	-0.5	0.16	-0.04	-0.14		0.31	-0.15	0.51	-0.18	-0.04	-0.24	0.09
Pocfratio	0.84	0.86	0.6	0.44	0.04	-0.84	-0.55	0.31	0.6	0.87	-0.55	-0.54	0.27	-0.42	-0.3	0.14	-0.13	0.36	0.31		-0.54	0.86	0.38	0.09	-0.32	-0.19
Interest Coverage	-0.46	-0.55	-0.27	-0.22	-0.24	0.79	0.47	-0.01	-0.27	-0.5	0.4	0.01	-0.37	-0.07	0.4	-0.18	0.28	-0.1	-0.15	-0.54		-0.55	-0.15	-0.14	0.57	0.48
Payout Ratio	0.74	1.0	0.38	0.47	0.44	-0.88	-0.19	0.17	0.38	0.8	-0.33	-0.78	0.65	-0.58	-0.64	0.25	-0.47	0.33	0.51	0.86	-0.55		0.35	0.24	-0.31	-0.12
Capex To Operating Cash Flow	0.1	0.35	-0.1	0.52	-0.02	-0.56	-0.45	0.85	-0.1	0.11	-0.74	-0.33	-0.07	-0.53	0.07	-0.03	-0.05	0.97	-0.18	0.38	-0.15	0.35		0.26	0.18	-0.18
Pfcf Ratio	-0.06	0.24	-0.3	0.35	0.41	-0.28	-0.02	-0.14	-0.3	0.02	-0.36	-0.33	0.33	-0.57	-0.32	-0.13	-0.39	0.17	-0.04	0.09	-0.14	0.24	0.26		0.53	-0.3
Days Payables Outstanding	-0.37	-0.31	-0.28	-0.08	-0.03	0.36	0.15	0.08	-0.28	-0.42	-0.01	-0.09	-0.29	-0.31	0.27	-0.64	0.14	0.14	-0.24	-0.32	0.57	-0.31	0.18	0.53		-0.2
Income Quality	-0.09	-0.12	-0.04	-0.22	0.01	0.35	0.51	-0.06	-0.04	-0.06	0.44	-0.1	-0.01	-0.05	0.02	0.71	-0.07	-0.08	0.09	-0.19	0.48	-0.12	-0.18	-0.3	-0.2

Click cells to compare fundamentals

HealthEquity Account Relationship Matchups

HealthEquity fundamentals Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Price To Sales Ratio	8.32	8.49	5.87	5.96	6.47	6.57
Ptb Ratio	4.3	4.51	2.4	2.71	3.18	5.64
Days Sales Outstanding	48.62	36.21	42.18	41.02	38.3	30.22
Book Value Per Share	15.37	18.57	22.28	22.45	23.78	24.97
Free Cash Flow Yield	0.0144	0.0136	8.81E-4	0.006135	0.0304	0.0277
Operating Cash Flow Per Share	1.58	2.45	1.7	1.78	2.84	2.98
Stock Based Compensation To Revenue	0.0749	0.0584	0.0697	0.0727	0.0772	0.0409
Capex To Depreciation	0.76	0.84	1.0	0.74	0.3	0.29
Pb Ratio	4.3	4.51	2.4	2.71	3.18	5.64
Ev To Sales	10.41	9.5	6.91	6.82	7.0	6.59
Free Cash Flow Per Share	0.95	1.14	0.0471	0.37	2.3	2.41
Roic	0.0304	0.0724	0.008034	0.009242	0.0326	0.031
Net Income Per Share	0.59	0.12	(0.53)	(0.31)	0.65	0.48
Payables Turnover	51.78	197.17	12.09	26.74	31.31	33.4
Capex To Revenue	0.0791	0.13	0.18	0.14	0.0461	0.0438
Cash Per Share	2.86	4.43	2.71	3.01	4.72	3.03
Pocfratio	41.83	34.27	31.51	34.11	26.63	26.98
Capex To Operating Cash Flow	0.4	0.53	0.97	0.79	0.19	0.18
Pfcf Ratio	69.42	73.53	1.1K	163.0	32.87	31.22
Days Payables Outstanding	7.05	1.85	30.2	13.65	11.66	16.01
Income Quality	2.67	20.56	(3.18)	(5.76)	4.36	3.88
Roe	0.0385	0.006407	(0.0239)	(0.0138)	0.0274	0.026
Ev To Operating Cash Flow	52.31	38.38	37.06	39.02	28.81	27.43
Pe Ratio	111.63	704.62	(100.31)	(196.55)	116.08	72.27
Ev To Free Cash Flow	86.81	82.34	1.3K	186.48	35.56	33.78
Earnings Yield	0.0192	0.008958	0.001419	(0.009969)	(0.005088)	0.008615
Intangibles To Total Assets	0.17	0.83	0.77	0.84	0.79	0.42
Net Debt To E B I T D A	9.0	4.82	7.6	4.32	1.87	1.97
Current Ratio	1.95	2.25	2.29	2.92	4.76	7.68
Tangible Book Value Per Share	(16.22)	(9.63)	(9.22)	(8.16)	(5.25)	(4.99)
Receivables Turnover	7.51	10.08	8.65	8.9	9.53	10.77
Graham Number	14.31	7.05	16.34	12.51	18.67	19.6
Shareholders Equity Per Share	15.37	18.57	22.28	22.45	23.78	24.97

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

RSI	Rush Street Interactive
OKTA	Okta Inc
BAC	Bank of America

Additional Tools for HealthEquity Stock Analysis

When running HealthEquity's price analysis, check to measure HealthEquity's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy HealthEquity is operating at the current time. Most of HealthEquity's value examination focuses on studying past and present price action to predict the probability of HealthEquity's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move HealthEquity's price. Additionally, you may evaluate how the addition of HealthEquity to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Price To Sales Ratio	Dividend Yield
Ptb Ratio	Days Sales Outstanding
Book Value Per Share	Free Cash Flow Yield
Invested Capital	Operating Cash Flow Per Share
Average Payables	Stock Based Compensation To Revenue
Capex To Depreciation	Pb Ratio
Ev To Sales	Free Cash Flow Per Share
Roic	Inventory Turnover
Net Income Per Share	Days Of Inventory On Hand
Payables Turnover	Sales General And Administrative To Revenue
Average Inventory	Research And Ddevelopement To Revenue
Capex To Revenue	Cash Per Share
Pocfratio	Interest Coverage
Payout Ratio	Capex To Operating Cash Flow
Pfcf Ratio	Days Payables Outstanding
Net Current Asset Value	Income Quality
Roe	Tangible Asset Value
Ev To Operating Cash Flow	Pe Ratio
Return On Tangible Assets	Ev To Free Cash Flow
Earnings Yield	Intangibles To Total Assets
Net Debt To E B I T D A	Current Ratio
Tangible Book Value Per Share	Receivables Turnover
Graham Number	Shareholders Equity Per Share
Debt To Equity	Capex Per Share
Graham Net Net	Average Receivables
Revenue Per Share	Interest Debt Per Share
Debt To Assets	Enterprise Value Over E B I T D A
Short Term Coverage Ratios	Price Earnings Ratio
Operating Cycle	Price Book Value Ratio
Price Earnings To Growth Ratio	Days Of Payables Outstanding
Dividend Payout Ratio	Price To Operating Cash Flows Ratio
Price To Free Cash Flows Ratio	Pretax Profit Margin
Ebt Per Ebit	Operating Profit Margin
Effective Tax Rate	Company Equity Multiplier
Long Term Debt To Capitalization	Total Debt To Capitalization
Return On Capital Employed	Debt Equity Ratio
Ebit Per Revenue	Quick Ratio
Dividend Paid And Capex Coverage Ratio	Net Income Per E B T
Cash Ratio	Cash Conversion Cycle
Operating Cash Flow Sales Ratio	Days Of Inventory Outstanding
Days Of Sales Outstanding	Free Cash Flow Operating Cash Flow Ratio
Cash Flow Coverage Ratios	Price To Book Ratio
Fixed Asset Turnover	Capital Expenditure Coverage Ratio
Price Cash Flow Ratio	Enterprise Value Multiple
Debt Ratio	Cash Flow To Debt Ratio
Price Sales Ratio	Return On Assets
Asset Turnover	Net Profit Margin
Gross Profit Margin	Price Fair Value
Return On Equity

HealthEquity Historical Financial Ratios

About HealthEquity Financial Ratios Analysis

HealthEquity Financial Ratios Chart

Price To Sales Ratio

Dividend Yield

Ptb Ratio

HealthEquity fundamentals Correlations

HealthEquity Account Relationship Matchups

High Positive Relationship

High Negative Relationship

HealthEquity fundamentals Accounts

Also Currently Popular

Additional Tools for HealthEquity Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Payout Ratio	+ 1.0	Dividend Yield
Pb Ratio	+ 1.0	Ptb Ratio
Ev To Sales	+ 0.97	Price To Sales Ratio
Capex To Operating Cash Flow	+ 0.97	Capex To Revenue
Capex To Revenue	+ 0.91	Capex To Depreciation
Ptb Ratio	+ 0.88	Price To Sales Ratio

Days Of Inventory On Hand	- 0.98	Inventory Turnover
Average Inventory	- 0.96	Book Value Per Share
Payout Ratio	- 0.88	Free Cash Flow Yield
Free Cash Flow Yield	- 0.88	Dividend Yield
Pocfratio	- 0.84	Free Cash Flow Yield
Days Of Inventory On Hand	- 0.79	Book Value Per Share